V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10445873 | 10033856 | 1.65 | 78.5 | Disease modification (D) | 2015-11-18 | 2019-02-11 | Rituximab | 02 | N | PEMBROLIZUMAB | 100904422 |
| 10445884 | 10033857 | 1.8 | 78.6 | Neo-adjuvant (N) | 2020-11-18 | 2020-11-25 | Capecitabine + Oxaliplatin 21day | 02 | null | RITUXIMAB | 101615329 |
| 10445886 | 10033858 | 1.79 | 68.4 | Curative (C) | 2017-08-19 | 2017-08-19 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE | 100577219 |
| 10445911 | 10033859 | 1.67 | 80.9 | Curative (C) | 2018-11-28 | 2018-11-28 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100143393 |
| 10445930 | 10033860 | 1.49 | 96.3 | Palliative (P) | 2020-02-28 | 2020-03-10 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE + OXALIPLATIN | 100953445 |
| 10445935 | 10033861 | 1.7 | 116.6 | null | 2021-10-28 | 2021-11-17 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE + OXALIPLATIN | 100783326 |
| 10445942 | 10033862 | 1.57 | 71.7 | null | 2022-02-24 | 2022-03-21 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE + OXALIPLATIN | 100680736 |
| 10445944 | 10033863 | 1.63 | 68.9 | Curative (C) | 2018-06-27 | 2018-06-28 | CAPECITABINE + OXALIPLATIN | 02 | N | DOCETAXEL | 101460681 |
| 10445949 | 10033864 | 1.74 | null | 03 | 2017-09-09 | 2019-05-17 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101861573 |
| 10445952 | 10033865 | 1.51 | null | 03 | 2018-07-29 | 2018-08-04 | IBRUTINIB | N | N | IBRUTINIB | 100100699 |
| 10445959 | 10033866 | 1.66 | 57.7 | Curative (C) | 2018-02-04 | 2018-02-17 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 100775053 |
| 10445969 | 10033867 | 1.46 | 0 | null | 2022-02-09 | 2022-02-16 | CHOP R - 21 days | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101262407 |
| 10445973 | 10033868 | 1.63 | 82.1 | Adjuvant (A) | 2018-12-05 | 2018-12-16 | CAPECITABINE + OXALIPLATIN | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100299074 |
| 10446029 | 10033869 | 1.76 | 65.3 | Curative (C) | 2019-05-02 | 2019-05-22 | Capecitabine + Oxaliplatin 21day | 02 | N | DOCETAXEL | 101333835 |
| 10446034 | 10033870 | 1.68 | 90.4 | 03 | 2018-11-19 | 2018-11-26 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 100545731 |
| 10446054 | 10033871 | 0 | 94 | null | 2017-08-11 | 2017-08-26 | Capecitabine + Oxaliplatin 21day | 99 | null | IBRUTINIB | 100535350 |
| 10446061 | 10033872 | 1.68 | 0 | Palliative (P) | 2017-01-04 | 2017-01-17 | CAPECITABINE + OXALIPLATIN | 02 | N | PEMBROLIZUMAB | 101535226 |
| 10446076 | 10033873 | 1.7 | 43.8 | Curative (C) | 2021-12-30 | 2021-12-30 | CAPECITABINE + OXALIPLATIN | 02 | null | DOCETAXEL | 100303529 |
| 10446079 | 10033874 | 1.76 | 70 | null | 2018-07-15 | 2018-07-15 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE + OXALIPLATIN | 100749561 |
| 10446086 | 10033875 | 1.78 | 57 | Palliative (P) | 2018-01-10 | 2018-01-19 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 101434184 |
| 10446087 | 10033876 | 1.67 | 83.2 | null | 2018-09-19 | 2018-10-16 | Rituximab (Maintenance) | 02 | null | RITUXIMAB | 101736446 |
| 10446121 | 10033877 | 1.8 | 51.8 | Curative (C) | 2016-07-13 | 2016-07-18 | CAPECITABINE + OXALIPLATIN | N | N | PEMBROLIZUMAB | 100231548 |
| 10446135 | 10033878 | 1.59 | 76.5 | Adjuvant (A) | 2019-04-07 | 2019-04-07 | CAPECITABINE + OXALIPLATIN | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101448075 |
| 10446158 | 10033879 | 1.5 | 0 | null | 2020-04-29 | 2020-05-12 | Capecitabine + Oxaliplatin 21day | 02 | null | IBRUTINIB | 100418986 |
| 10446165 | 10033880 | 1.7 | 56 | 03 | 2019-12-01 | 2019-12-23 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100302528 |
| 10446184 | 10033881 | 1.56 | 69 | null | 2019-05-19 | 2019-06-03 | Capecitabine + Oxaliplatin 21day | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101169787 |
| 10446200 | 10033882 | null | 54 | Curative (C) | 2013-04-22 | 2017-11-27 | IBRUTINIB | 02 | N | IBRUTINIB | 100042808 |
| 10446233 | 10033883 | 1.7 | 111 | Palliative (P) | 2017-08-21 | 2017-09-05 | CAPECITABINE + OXALIPLATIN | N | N | CAPECITABINE + OXALIPLATIN | 101410933 |
| 10446259 | 10033884 | 1.76 | 58 | Adjuvant (A) | 2019-06-02 | 2019-06-16 | CAPECITABINE + OXALIPLATIN | 02 | N | PEMBROLIZUMAB | 100394590 |
| 10446267 | 10033885 | 1.76 | 62.8 | Adjuvant (A) | 2019-12-23 | 2020-01-20 | Capecitabine + Oxaliplatin 21day | 02 | N | RITUXIMAB | 101541529 |
| 10446290 | 10033886 | 1.73 | 86.4 | null | 2022-04-12 | 2022-04-12 | IBRUTINIB | N | null | IBRUTINIB | 101433728 |
| 10446310 | 10033887 | 1.74 | 87.7 | Palliative (P) | 2018-01-20 | 2018-02-02 | CHOP R | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101451788 |
| 10446316 | 10033888 | 1.8 | 79.9 | Adjuvant (A) | 2020-02-22 | 2020-02-23 | Capecitabine | 02 | N | CAPECITABINE | 101781748 |
| 10446330 | 10033889 | 0 | 103 | Adjuvant (A) | 2017-09-13 | 2017-09-13 | IBRUTINIB | 02 | N | IBRUTINIB | 100320280 |
| 10446332 | 10033890 | 1.65 | 72.8 | null | 2020-02-24 | 2020-03-30 | IBRUTINIB | 02 | null | IBRUTINIB | 101708207 |
| 10446342 | 10033891 | null | 108.8 | Palliative (P) | 2017-04-07 | 2017-04-25 | PEMBROLIZUMAB | N | N | PEMBROLIZUMAB | 100565257 |
| 10446349 | 10033892 | 1.66 | 46.7 | null | 2017-05-03 | 2017-05-29 | IBRUTINIB | 02 | null | IBRUTINIB | 101024595 |
| 10446364 | 10033893 | 1.75 | 66.4 | Palliative (P) | 2017-09-24 | 2017-09-24 | Capecitabine + Oxaliplatin 21day | N | N | DOCETAXEL | 100428087 |
| 10446373 | 10033894 | 1.58 | 73.8 | Palliative (P) | 2021-06-08 | 2021-06-25 | CHOP R - 21 days | 02 | null | PEMBROLIZUMAB | 100981371 |
| 10446378 | 10033895 | 1.64 | 89.7 | null | 2022-03-03 | 2022-03-09 | CHOP R | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101432652 |
| 10446387 | 10033896 | 1.63 | 85 | Adjuvant (A) | 2019-03-03 | 2019-03-09 | IBRUTINIB | N | N | IBRUTINIB | 100982725 |
| 10446392 | 10033897 | 1.65 | 69.8 | 03 | 2016-12-23 | 2017-01-10 | CHOP R | N | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100916971 |
| 10446397 | 10033898 | 0 | 83.3 | null | 2022-03-13 | 2022-04-20 | IBRUTINIB | 02 | null | IBRUTINIB | 100979295 |
| 10446420 | 10033899 | 1.51 | 77 | Curative (C) | 2017-01-01 | 2017-01-02 | CAPECITABINE + OXALIPLATIN | 2 | N | CAPECITABINE + OXALIPLATIN | 100561310 |
| 10446441 | 10033900 | 1.8 | 159.9 | null | 2020-11-23 | 2020-11-29 | CAPECITABINE + OXALIPLATIN | 02 | N | RITUXIMAB | 101542793 |
| 10446445 | 10033901 | 0.02 | 86.2 | Curative (C) | 2018-04-16 | 2018-04-18 | IBRUTINIB | 2 | N | IBRUTINIB | 100604133 |
| 10446496 | 10033902 | 1.52 | 105 | 03 | 2019-07-10 | 2019-07-29 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 101176292 |
| 10446505 | 10033903 | 1.74 | null | null | 2018-01-27 | 2018-01-27 | IBRUTINIB | 02 | null | IBRUTINIB | 100473424 |
| 10446529 | 10033904 | 1.07 | 66 | 03 | 2017-08-18 | 2017-09-19 | Rituximab (Maintenance) | 02 | N | RITUXIMAB | 100717813 |
| 10446557 | 10033905 | 1.75 | 75.8 | null | 2020-01-20 | 2020-01-24 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE + OXALIPLATIN | 101250706 |